Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The company manufactures and distributes branded concentrates, syrup, and finished beverages, as well as sales of owned brands and third-party brands; tea, cocoa, and other products; and offers finished goods relating to K-Cup pods, single serve brewers, specialty coffee, and ready to drink coffee products. It offers its products under the Dr Pepper, Canada Dry, Mott's, A&W, Peñafiel, Snapple, 7UP, Green Mountain Coffee Roasters, GHOST, Clamato, Core Hydration, The Original Donut Shop, Snapple, Sunkist soda, Squirt, C4 Energy, Hawaiian Punch, Electrolit, Bai, Evian, Yoo-Hoo, Vita Coco, Big Red, Mott's, Crush, McCafé, Tim Hortons, Van Houtte, Celestial Seasonings, Bigelow, Starbucks, Dunkin', Folgers, Peet's, and Swiss Miss brands, as well as other partner and private label brands. The company markets and sells its products to supermarkets, mass merchandisers, club stores, pure-play e-commerce retailers, office superstores, restaurants, hotel chains, office product and coffee distributors, partner brand owners, and directly to consumers through Keurig.com website. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Burlington, Massachusetts.

Keurig Dr Pepper Inc.

Morgan Stanley analyst Dara Mohsenian reiterated a Buy rating on Keurig Dr Pepper yesterday and set a price target of $38.00. The company’s shares ...

Morgan Stanley Remains a Buy on Keurig Dr Pepper (KDP)

Analysts are intrested in these 5 stocks: ( ($KDP) ), ( ($RARE) ), ( ($INCY) ), ( ($PRQR) ) and ( ($AUPH) ). Here is a breakdown of their recent


KDP, Ultragenyx, Incyte, ProQR, Aurinia Trending With Analysts

In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper, with a price target of $38.00. Lieberman co...

Barclays Remains a Buy on Keurig Dr Pepper (KDP)

RBC Capital analyst Nik Modi maintained a Buy rating on Keurig Dr Pepper on August 4 and set a price target of $42.00. The company’s shares closed ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	KDP	$33.05	+1.40%	2.89M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	KDP	$33.05	+1.4%	2.89M
3
4
5
6

KDP

Get Keurig Dr Pepper Inc. Data in Excel

Get Keurig Dr Pepper Inc. Data in Excel